Ad is loading...
RYLDX
Price
$185.76
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
RYVLX
Price
$571.07
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

RYLDX vs RYVLX

Header iconRYLDX vs RYVLX Comparison
Open Charts RYLDX vs RYVLXBanner chart's image
Rydex Dow 2x Strategy A
Price$185.76
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Rydex NASDAQ-100® 2x Strategy A
Price$571.07
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
RYLDX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYLDX vs. RYVLX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLDX is a Buy and RYVLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.38B vs. RYLDX (45M). RYLDX pays higher dividends than RYVLX: RYLDX (0.37) vs RYVLX (0.00). RYLDX was incepted earlier than RYVLX: RYLDX (20 years) vs RYVLX (20 years). RYLDX is a more actively managed with annual turnover of: 516.00 vs. RYVLX (461.00). RYLDX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 53.22 vs. RYLDX (46.59). RYVLX return over 5 years is better than : 212.88 vs. RYLDX (74.61).
RYLDXRYVLXRYLDX / RYVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years20 years-
Gain YTD29.01839.61973%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets45M1.38B3%
Annual Yield % from dividends0.370.00-
Returns for 1 year46.5953.2288%
Returns for 3 years24.5310.72229%
Returns for 5 years74.61212.8835%
Returns for 10 years267.47655.5241%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PK14.680.48
+3.38%
Park Hotels & Resorts
VITL31.030.90
+2.99%
Vital Farms
PTC192.754.25
+2.25%
PTC
ZNTL3.180.05
+1.60%
Zentalis Pharmaceuticals
BOLT0.57N/A
-0.56%
Bolt Biotherapeutics